+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Interventional Radiology Market Growth Analysis - Market Size, Share, Forecast Trends and Outlook Report (2025-2034)

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163365
The global interventional radiology market size reached around USD 24.20 Billion in 2024. The market is projected to grow at a CAGR of 6.70% between 2025 and 2034 to reach nearly USD 46.29 Billion by 2034.

Global Interventional Radiology Market Overview

Interventional radiology (IR) refers to a collection of methods that direct medical imaging like x-ray fluoroscopy, magnetic resonance imaging, computed tomography, or ultrasound to guide medical therapies via very small incisions specifically towards the internal structure of the body. The interventional radiology market growth is driven by several factors including its expanded application across different domains like cardiology, musculoskeletal interventions, oncology, and neurology. The rising prevalence for minimally invasive procedures, along with patient centric approaches, personalized treatment plans and integration of artificial intelligence and robotics, also contribute to the rising market value.

New Product Launches to Meet the Rising Interventional Radiology Market Demand

In May 2023, United Imaging launched an entire range of products imaging and digital solutions, enabled with artificial intelligence capacity across multiple modalities. Some of the notable inventions include the uRT-linac 506c, a LINAC device that combines a diagnostic CT imager and a linear accelerator to offer continuous treatment simulation. Other cutting-edge solutions include PET/CT uEXPLORER®, the uMR® Jupiter 5.0T, uMI Panorama™, and the ultra-high-field preclinical 9.4T MR.

The interventional radiology market share is poised to grow further with multiple companies stepping up to unveil innovative and technology driven equipment. In September 2023, Canon Medical Systems Corporation introduced Alphenix Sky 12 HD interventional system that offers twice as much better resolution than the conventional flat panel detectors. With the new 12” × 12” high-definition (Hi-Def) detector, the system aims at offering improved interventional imaging efficiency for multiple domains, including neurology, cardiology, oncology, and pediatric care.

Surge in Investments to Offer Improved Solutions

In June 2023, Flow Medical, a University of Chicago startup, received a USD 1 million investment to develop and commercialize their latest multi-function catheter to help diagnose and treat venous thromboembolic disease. The funds are expected to expediate the device development and testing process so as to facilitate the submission for FDA 510(k) approval by the first quarter of 2025. The growth in investments for enhanced research activities in poised to boost the interventional radiology market growth in the forecast period.

Increasing Integration of Artificial Intelligence Based and Smart Solutions

The healthcare landscape is witnessing rising integration of smart and artificial intelligence run solutions. To offer improved patient and staff experience and drive operational efficiency at a lower cost of care, leading healthcare companies such as Royal Philips have started developing and applying smart connected imaging systems into relevant treatment plans. For instance, MR 5300 is an artificial intelligence run technology that automates several compound clinical and operational tasks to enhance clinical decision-making and speed up the imaging process. The rising application of latest technologies in the radiology scenario is likely to drive a significant upswing in the interventional radiology market size.

In addition, the advent of Phillips MR 7700 in 3.0T imaging is a breakthrough as it facilitates an enhanced gradient system for better imaging results. Along with an improved image quality, it has reduced the scan time by 35% enabling and allows imaging six different nuclei at the same time, which has been a major help for radiologists.

Global Interventional Radiology Market Segmentation

Market Breakup by Products

  • MRI Systems
  • CT Scanners
  • Ultrasound Imaging Systems
  • Angiography Systems
  • Biopsy Devices
  • Fluoroscopy Systems
  • Others

Market Breakup by Technology

  • Catheters
  • Stents
  • Inferior Vena Cava (IVC) Filters
  • Hemodynamic Flow Alteration (HFA) Devices
  • Angioplasty Balloons
  • Thrombectomy Systems
  • Embolization Devices
  • Biopsy Needles
  • Accessories
  • Others

Market Breakup by Procedure

  • Angioplasty
  • Angiography
  • Embolization
  • Thrombolysis
  • Biopsy and Drainage
  • Vertebroplasty
  • Nephrostomy
  • Other Procedures

Market Breakup by Application

  • Cardiology
  • Urology and Nephrology
  • Oncology
  • Gastroenterology
  • Obstetrics
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Interventional Radiology Market Regional Analysis

The United States is anticipated to lead the global market owing to the presence of prominent healthcare companies. The presence of a robust healthcare infrastructure aids the market share as well. The region is witnessing continuous infrastructure related developments. In October 2023, Children's Hospital Los Angeles opened a new interventional radiology suite with latest technology aimed at improving patient care. This hospital is likely to contribute significantly to the rising interventional radiology market share in the coming years.

The new diagnostic facility for children includes state-of-the-art machinery that combines fluoroscopy and CT scanning. It also includes a biplane angiography machine to allow radiologists to make videos during X-ray procedures. The opening of such facilities is expected to improve the accessibility for advanced imaging alternatives, ensuring quality care and patient safety.

Global Interventional Radiology Market: Competitor Landscape

In January 2023, GE Healthcare acquired Imactis, a French CT interventional guidance technology to strengthen their imaging technology portfolio by leveraging the IMACTIS CT-Navigation system. An ergonomic universal solution, CT-Navigation™ offers stereotactic needle guidance for continuous and pre-planned control across several diagnostics to treatments. With this acquisition, GE has showed the intent of expanding their technologies into image guided therapies business to maximize growth.

The key features of the interventional radiology market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • General Electric
  • Koninklijke Philips N.V.
  • Carestream Health
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Canon Medical Systems Corporation
  • Samsung Medison Co., Ltd.
  • Medtronic Plc
  • Agfa-Gevaert Group
  • Teleflex Incorporated
  • Analogic Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Trivitron Healthcare
  • Stryker Corporation
  • Olympus Corporation
  • Toshiba Medical Systems
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Interventional Radiology Market Overview
3.1 Global Interventional Radiology Market Historical Value (2018-2024)
3.2 Global Interventional Radiology Market Forecast Value (2025-2034)
4 Global Interventional Radiology Market Landscape*
4.1 Global Interventional Radiology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Interventional Radiology: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
5 Global Interventional Radiology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Interventional Radiology Market Segmentation (2018-2034)
6.1 Global Interventional Radiology Market (2018-2034) by Products
6.1.1 Market Overview
6.1.2 MRI Systems
6.1.3 CT Scanners
6.1.4 Ultrasound Imaging Systems
6.1.5 Angiography Systems
6.1.6 Biopsy Devices
6.1.7 Fluoroscopy Systems
6.1.8 Others
6.2 Global Interventional Radiology Market (2018-2034) by Technology
6.2.1 Market Overview
6.2.2 Catheters
6.2.3 Stents
6.2.4 Inferior Vena Cava (IVC) Filters
6.2.5 Hemodynamic Flow Alteration (HFA) Devices
6.2.6 Angioplasty Balloons
6.2.7 Thrombectomy Systems
6.2.8 Embolization Devices
6.2.9 Biopsy Needles
6.2.10 Accessories
6.2.11 Others
6.3 Global Interventional Radiology Market (2018-2034) by Procedure
6.3.1 Market Overview
6.3.2 Angioplasty
6.3.3 Angiography
6.3.4 Embolization
6.3.5 Thrombolysis
6.3.6 Biopsy and Drainage
6.3.7 Vertebroplasty
6.3.8 Nephrostomy
6.3.9 Other Procedures
6.4 Global Interventional Radiology Market (2018-2034) by Application
6.4.1 Market Overview
6.4.2 Cardiology
6.4.3 Urology and Nephrology
6.4.4 Oncology
6.4.5 Gastroenterology
6.4.6 Obstetrics
6.4.7 Others
6.5 Global Interventional Radiology Market (2018-2034) by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Clinics
6.5.4 Ambulatory Surgical Centres
6.5.5 Others
6.6 Global Interventional Radiology Market (2018-2034) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Interventional Radiology Market (2018-2034)
7.1 North America Interventional Radiology Market (2018-2034) by Products
7.1.1 Market Overview
7.1.2 MRI Systems
7.1.3 CT Scanners
7.1.4 Ultrasound Imaging Systems
7.1.5 Angiography Systems
7.1.6 Biopsy Devices
7.1.7 Fluoroscopy Systems
7.1.8 Others
7.2 North America Interventional Radiology Market (2018-2034) by Procedure
7.2.1 Market Overview
7.2.2 Angioplasty
7.2.3 Angiography
7.2.4 Embolization
7.2.5 Thrombolysis
7.2.6 Biopsy and Drainage
7.2.7 Vertebroplasty
7.2.8 Nephrostomy
7.2.9 Other Procedures
7.3 North America Interventional Radiology Market (2018-2034) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Interventional Radiology Market (2018-2034)
8.1 Europe Interventional Radiology Market (2018-2034) by Products
8.1.1 Market Overview
8.1.2 MRI Systems
8.1.3 CT Scanners
8.1.4 Ultrasound Imaging Systems
8.1.5 Angiography Systems
8.1.6 Biopsy Devices
8.1.7 Fluoroscopy Systems
8.1.8 Others
8.2 Europe Interventional Radiology Market (2018-2034) by Procedure
8.2.1 Market Overview
8.2.2 Angioplasty
8.2.3 Angiography
8.2.4 Embolization
8.2.5 Thrombolysis
8.2.6 Biopsy and Drainage
8.2.7 Vertebroplasty
8.2.8 Nephrostomy
8.2.9 Other Procedures
8.3 Europe Interventional Radiology Market (2018-2034) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Interventional Radiology Market (2018-2034)
9.1 Asia Pacific Interventional Radiology Market (2018-2034) by Products
9.1.1 Market Overview
9.1.2 MRI Systems
9.1.3 CT Scanners
9.1.4 Ultrasound Imaging Systems
9.1.5 Angiography Systems
9.1.6 Biopsy Devices
9.1.7 Fluoroscopy Systems
9.1.8 Others
9.2 Asia Pacific Interventional Radiology Market (2018-2034) by Procedure
9.2.1 Market Overview
9.2.2 Angioplasty
9.2.3 Angiography
9.2.4 Embolization
9.2.5 Thrombolysis
9.2.6 Biopsy and Drainage
9.2.7 Vertebroplasty
9.2.8 Nephrostomy
9.2.9 Other Procedures
9.3 Asia Pacific Interventional Radiology Market (2018-2034) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Interventional Radiology Market (2018-2034)
10.1 Latin America Interventional Radiology Market (2018-2034) by Products
10.1.1 Market Overview
10.1.2 MRI Systems
10.1.3 CT Scanners
10.1.4 Ultrasound Imaging Systems
10.1.5 Angiography Systems
10.1.6 Biopsy Devices
10.1.7 Fluoroscopy Systems
10.1.8 Others
10.2 Latin America Interventional Radiology Market (2018-2034) by Procedure
10.2.1 Market Overview
10.2.2 Angioplasty
10.2.3 Angiography
10.2.4 Embolization
10.2.5 Thrombolysis
10.2.6 Biopsy and Drainage
10.2.7 Vertebroplasty
10.2.8 Nephrostomy
10.2.9 Other Procedures
10.3 Latin America Interventional Radiology Market (2018-2034) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Interventional Radiology Market (2018-2034)
11.1 Middle East and Africa Interventional Radiology Market (2018-2034) by Products
11.1.1 Market Overview
11.1.2 MRI Systems
11.1.3 CT Scanners
11.1.4 Ultrasound Imaging Systems
11.1.5 Angiography Systems
11.1.6 Biopsy Devices
11.1.7 Fluoroscopy Systems
11.1.8 Others
11.2 Middle East and Africa Interventional Radiology Market (2018-2034) by Procedure
11.2.1 Market Overview
11.2.2 Angioplasty
11.2.3 Angiography
11.2.4 Embolization
11.2.5 Thrombolysis
11.2.6 Biopsy and Drainage
11.2.7 Vertebroplasty
11.2.8 Nephrostomy
11.2.9 Other Procedures
11.3 Middle East and Africa Interventional Radiology Market (2018-2034) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 General Electric
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Koninklijke Philips N.V.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Carestream Health
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Hitachi, Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hologic, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Shimadzu Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Siemens Healthcare GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Canon Medical Systems Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Samsung Medison Co., Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Medtronic Plc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Agfa-Gevaert Group
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Teleflex Incorporated
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Analogic Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Trivitron Healthcare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Stryker Corporation
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Olympus Corporation
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Toshiba Medical Systems
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
18 Global Interventional Radiology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • General Electric
  • Koninklijke Philips N.V.
  • Carestream Health
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Canon Medical Systems Corporation
  • Samsung Medison Co., Ltd.
  • Medtronic Plc
  • Agfa-Gevaert Group
  • Teleflex Incorporated
  • Analogic Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Trivitron Healthcare
  • Stryker Corporation
  • Olympus Corporation
  • Toshiba Medical Systems